Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Robert Somerville"'
Autor:
John R. Wunderlich, Daniel J. Stephens, Liqiang Xi, Biman C. Paria, Smita S. Chandran, Arvind Sabesan, Mark Raffeld, Parthav Jailwala, Manjula Kasoji, Robert Somerville, Chyi-Chia Richard Lee, Trinh Hoc Tran Pham, Luke D. Rothermel, Abhishek K. Srivastava, Udai S. Kammula
Publikováno v:
Clinical Cancer Research. 22:2237-2249
Purpose: Uveal melanoma is a rare melanoma variant with no effective therapies once metastases develop. Although durable cancer regression can be achieved in metastatic cutaneous melanoma with immunotherapies that augment naturally existing antitumor
Autor:
Kathleen E. Morton, Udai S. Kammula, David N. Danforth, Thomas E. Shelton, Sadia Ilyas, Richard M. Sherry, Mary Ann Toomey, Eden C. Payabyab, Donald E. White, Seth M. Steinberg, Nicholas P. Restifo, Christopher A. Klebanoff, Michael S. Hughes, Steven A. Rosenberg, Mark E. Dudley, Deborah Citrin, Lily Lu, Nicholas D. Klemen, Mei Li M. Kwong, Daniel Zlott, James Chih-Hsin Yang, Michelle M. Langhan, John R. Wunderlich, Robert Somerville, Stephanie L. Goff
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 34(20)
Purpose Adoptive cell transfer, the infusion of large numbers of activated autologous lymphocytes, can mediate objective tumor regression in a majority of patients with metastatic melanoma (52 of 93; 56%). Addition and intensification of total body i
Autor:
Steven A. Rosenberg, Victoria Shi, Tangying L. Lu, Roger Kurlander, R. E. Gress, Brenna G. Hansen, Dennis D. Hickstein, Jeremy J. Rose, Steven A. Feldman, Jennifer N. Brudno, David Halverson, Bazetta Blacklock-Schuver, Irina Maric, Jennifer S. Wilder, Daniel H. Fowler, Robert Somerville, Juan C. Gea-Banacloche, Frances T. Hakim, Steven Z. Pavletic, James N. Kochenderfer, Andre Goy, Alexander T. Iwamoto
Purpose Progressive malignancy is the leading cause of death after allogeneic hematopoietic stem-cell transplantation (alloHSCT). After alloHSCT, B-cell malignancies often are treated with unmanipulated donor lymphocyte infusions (DLIs) from the tran
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78731f1c73af0683f0b5eca4e5d2e804
https://europepmc.org/articles/PMC4872017/
https://europepmc.org/articles/PMC4872017/